Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurocutaneous Syndromes”

465 trials

Showing 20 of 465 results

Not applicableStudy completedNCT04198207
What this trial is testing

The Effectiveness and Safety of Vagus Nerve Stimulation for TRE

Who this might be right for
Tuberous Sclerosis ComplexEpilepsy
Beijing Children's Hospital 70
Early research (Phase 1)Study completedNCT02211768
What this trial is testing

Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1

Who this might be right for
NeurofibromatosisMPNST
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05467397
What this trial is testing

Feasibility of [11C]Acetate-PET in LAM and TSC

Who this might be right for
LymphangioleiomyomatosisTuberous Sclerosis Complex
Brigham and Women's Hospital 7
Testing effectiveness (Phase 2)Ended earlyNCT01968590
What this trial is testing

Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)

Who this might be right for
Neurofibromatosis Type 1 (NF1)
University of Utah 26
Not applicableStudy completedNCT02325505
What this trial is testing

Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosisAngiomyolipoma
InCor Heart Institute 200
Testing effectiveness (Phase 2)Study completedNCT05005845
What this trial is testing

NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Who this might be right for
Cutaneous NeurofibromaNeurofibromatosis 1
NFlection Therapeutics, Inc. 199
Large-scale testing (Phase 3)Study completedNCT02471339
What this trial is testing

Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain

Who this might be right for
Neurofibromatosis Type 1Plexiform Neurofibromas
National Cancer Institute (NCI) 66
Not applicableUnknownNCT00951886
What this trial is testing

The Validity of Forced Expiratory Maneuvers in Ataxia Telangiectasia Studied Longitudinally

Who this might be right for
Ataxia Telangiectasia
Sheba Medical Center 28
Not applicableStudy completedNCT04717427
What this trial is testing

Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome

Who this might be right for
Sturge-Weber Syndrome
University of Illinois at Chicago 161
Not applicableWithdrawnNCT02309632
What this trial is testing

Pancreatic Cancer Screening of High-Risk Individuals in Arkansas

Who this might be right for
Pancreatic NeoplasmsPeutz-Jegher's SyndromeBRCA1 Gene Mutation+5 more
University of Arkansas
Testing effectiveness (Phase 2)Study completedNCT02934256
What this trial is testing

Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Who this might be right for
Vestibular SchwannomaNeurofibromatosis Type 2
Li Peng 10
Testing effectiveness (Phase 2)Study completedNCT04513002
What this trial is testing

Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With a Novel Form of Anaplerosis

Who this might be right for
Ataxia Telangiectasia
The University of Queensland 30
Testing effectiveness (Phase 2)Study completedNCT01289912
What this trial is testing

Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC)

Who this might be right for
Tuberous Sclerosis Complex
Mustafa Sahin 52
Testing effectiveness (Phase 2)UnknownNCT01954693
What this trial is testing

Everolimus in the Treatment of Neurocognitive Problems in Tuberous Sclerosis

Who this might be right for
Tuberous Sclerosis
Cardiff University 48
Not applicableUnknownNCT06324877
What this trial is testing

Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside

Who this might be right for
Ataxia Telangiectasia
The University of Queensland 10
Not applicableLooking for participantsNCT02420067
What this trial is testing

Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients

Who this might be right for
Von Hippel-Lindau Disease
Marie Luise Bisgaard, MD 380
Not applicableStudy completedNCT01364857
What this trial is testing

French National Cohort of Children With Port Wine Stain

Who this might be right for
Port Wine StainKlippel Trenaunay SyndromeParkes Weber Syndrome
University Hospital, Tours 150
Testing effectiveness (Phase 2)Looking for participantsNCT07237100
What this trial is testing

Mirdametinib in Patients With Advanced NF1-mutant Melanoma

Who this might be right for
Advanced Unresectable MelanomaMetastatic Melanoma
Kevin Kim, MD 10
Testing effectiveness (Phase 2)Study completedNCT04435665
What this trial is testing

NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Who this might be right for
Neurofibromatosis 1Cutaneous Neurofibroma
NFlection Therapeutics, Inc. 48
Not applicableEnded earlyNCT05683678
What this trial is testing

US Selumetinib Registry

Who this might be right for
Neurofibromatosis Type 1Plexiform Neurofibromas
Alexion Pharmaceuticals, Inc. 37
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation